← Back to all trials
Not Yet Recruiting
NCT07529457
Adults With Constipation
Conditions: Constipation
Sex: All
Ages: 18 Years – 65 Years
Healthy volunteers: Yes
Phase: NA
Enrollment: 70
Sponsor: Wecare Probiotics Co., Ltd.
Location: Suzhou Ninth People's Hospital Suzhou Jiangsu
Summary
This randomized, double-blind, placebo-controlled trial will assess the clinical effects of Akk09 in adults with functional constipation. Participants will receive Akk09 or placebo for 8 weeks. The study will evaluate changes in bowel habits and symptom burden, as well as alterations in host inflammatory status, immune modulation, microbial ecosystem dynamics, neuroendocrine signaling related to the gut-brain axis, and systemic metabolic responses, to characterize the overall physiological impact of Akk09 supplementation.
Eligibility Criteria
Inclusion Criteria:
1. Men and women aged between 18 and 65 years;
2. Participants presenting with constipation, characterized by \
Source: ClinicalTrials.gov (NCT07529457). StuddyBuddy aggregates publicly available trial information.
